Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Banyaknya jemaah haji Indonesia dengan kebiasaan merokok yang bisa menyebabkan gangguan faal paru. Gangguan faal paru tersebut bisa berupa obstruktif, restriktif, dan campuran. Belum ada penelitian tentang gambaran faal paru pada jemaah haji perokok di Indonesia. Tujuan: Mendapatkan karakteristik dan gambaran faal paru serta hubungan antara perilaku merokok dengan gambaran faal paru jemaah haji perokok pada jemaah haji embarkasi Jakarta-Pondok Gede tahun 2012. Metode: Disain studi adalah potong lintang pada jemaah haji perokok pada saat menjalani pemeriksaan kesehatan haji di Puskesmas Kecamatan dan Embarkasi Jakarta-Pondok Gede. Penilaian perilaku merokok berdasarkan Indeks Brinkman dan penilaian gambaran faal paru berdasarkan pemeriksaan spirometri. Analisis bivariat menggunakan metode Kolmogorov-Smirnov. Hasil: Pada studi ini didapatkan 209 subjek jemaah haji perokok. Karakteristik jemaah haji perokok umumnya laki-laki (99,5%), usia < 60 tahun (78,0%), IMT kategori lebih (63,2%), tidak disertai komorbid (68,9%), pendidikan kategori tinggi (75,1%), Indeks Brinkman kategori sedang (53,1%). Gambaran faal paru masuk kategori restriktif 51,2%, obtruktif 8,6%, campuran 8,1%, dan normal 32,1%. Penelitian ini tidak menunjukan hubungan bermakna antara perilaku merokok dengan gambaran faal paru pada kelompok kategori Indeks Brinkman sedang-berat dibandingkan kelompok kategori Indeks Brinkman ringan (p=0,925). Simpulan: Karakteristik jemaah haji perokok umumnya laki-laki, usia < 60 tahun, IMT kategori lebih, tidak disertai komorbid, pendidikan kategori tinggi, Indeks Brinkman kategori sedang. Gambaran faal paru umumnya masuk kategori restriktif. Penelitian ini tidak menunjukan adanya hubungan yang bermakna antara perilaku merokok dengan gambaran faal paru pada kelompok kategori Indeks Brinkmansedang-berat dibandingkan kelompok Indeks Brinkman ringan.

---

Background: There are many of Indonesian pilgrims who have smoking habits. Smoking can cause pulmonary function disorder. Pulmonary function could be normal, obstructive, restrictive, or mixed. Previous studies had showed a close association between smoking behavior and respiratory tract diseases. There is no research about pulmonary function on smoking Indonesian pilgrims.

Aims: To obtain characteristics of pulmonary function and the association between smoking behavior with pulmonary function on smoking Indonesian pilgrims at Jakarta-Pondok Gede embarkation in 2012.

Method: This was a cross-sectional study on smoking Indonesian pilgrims during Hajj health checkup at the health center and embarkation District of Jakarta-Pondok Gede. Assessment of smoking behavior based on Brinkman index and pulmonary function assessment based on spirometry screening using spirometry. Bivariate analysis using Kolmogorov-Smirnov.

Result: This study got 209 subjects of smoker pilgrims. Subjects are generally male (99.5%), < 60 years (78.0%), overweight (63.2%), no comorbidity (68.9%), high education level (75.1%), medium Brinkman index (53.1%). Pulmonary functions are categorized as restrictive 51.2%, obtructive 8,6%, mixed 8,1%, and normal 32,1%. This study showed no significant association between smoking behavior with pulmonary function in the medium-heavy Brinkman index group than the light Brinkman Index group (p = 0.925).

Conclusion: Subjects are generally male, < 60 years, overweight, no comorbidity, high education level, medium Brinkman index. Pulmonary functions are generally categorized as restrictive. This study showed no significant association between smoking behavior with pulmonary function in the medium-heavy Brinkman index group than the light Brinkman Index group."

"Latar Belakang: Mutasi Epidermal Growth Factor Receptor (EGFR) merupakan prediktor keberhasilan terapi TKI pada non-small cell lung cancer (NSCLC). Ras Asia, perempuan, bukan perokok, tipe histologis adenokarsinoma adalah karakteristik klinikopatologis yang diketahui memiliki asosiasi dengan mutasi EGFR pada NSCLC. Di Indonesia belum pernah dilakukan penelitian yang membuktikan asosiasi tersebut di tengah keterbatasan sumber daya dan fasilitas pemeriksaan biomolekuler untuk medeteksi mutasi EGFR.Metode: Desain studi adalah potong lintang. Subjek dikumpulkan secara konsekutif dari pasien adenokarsinoma paru stadium lanjut Rumah Sakit Umum Pusat Nasional Cipto Mangunkusumo dan Rumah Sakit Dharmais Pusat Kanker Nasional yang memeriksakan status mutasi EGFR di Laboratorium Kalbe Genomics dalam kurun waktu Januari 2010 hingga Desember 2013. Dari rekam medis pasien ditelusuri data umur, jenis kelamin, status merokok, diagnosis dan status mutasi EGFR. Uji chi-square dilanjutkan regresi logistik digunakan untuk menilai asosiasi jenis kelamin dan status merokok terhadap status mutasi EGFR.Hasil: Studi melibatkan 51 subjek dan didapatkan proporsi mutasi EGFR sebesar 47,1% (IK 95% = 33,4% – 60,8%). Uji bivariat menunjukkan perempuan (RO=4,80; IK 95%=1,12-20,61) dan bukan perokok (RO=4,00; IK 95%=1,23-13,06) memiliki asosiasi dengan mutasi EGFR, namun pada uji multivariat hanya status bukan perokok yang masih bermakna (RO=4,00; IK 95%=1,22-13,06).Simpulan: Proporsi mutasi EGFR pada kelompok pasien adenokarsinoma paru stadium lanjut 47,1%. Hanya status bukan perokok yang memiliki asosiasi independen dengan mutasi EGFR.

---

Background: Epidermal Growth Factor Receptor (EGFR) mutation is predictor for successful TKI therapy in non-small cell lung cancer (NSCLC) patient. Asian, women, non-smoker, and histology of adenocarcinoma are the clinicopathological characteristics associated with EGFR mutation in NSCLC patient. In Indonesia, no research has been performed to confirm association between those characteristics while the resources and facilities to detect EGFR mutation are lacking.

Method: A cross sectional study was performed in Cipto Mangunkusumo National Referral Hospital and Dharmais Hospital National Cancer Center from January 2010 to December 2013. Subjects were collected consecutively from advanced lung adenocarcinoma patients who underwent examination for EGFR mutation in Kalbe Genomics Laboratory during study period. From medical records, information about age, gender, smoking status, diagnosis, and EGFR mutation status were collected. Chi square and logistic regression analysis were performed to assess association between variables.

Results: From 51 subjects participated in this study, proportion of EGFR mutation was 47.1% (CI 95% = 33,4% – 60,8%). Bivariate analysis revealed that women (OR=4,80; CI 95%=1,12-20,61) and non-smoker (OR=4,00; CI 95%=1,23-13,06) were associated with EGFR mutation. While in multivariate analysis, non-smoker status was the only significant clinical factor associated with EGFR mutation (OR=4.00; CI 95%=1.22-13.06).

Conclusion: Proportion of EGFR mutation in advanced lung adenocarcinoma patients is 47,1%. Non-smoker status is the only clinical factor associated with EGFR mutation."

"ABSTRAKLatar Belakang. Ibadah haji merupakan ibadah fisik yang dilakukan oleh jemaah haji terdiri dari aktivitas berjalan minimal sejauh 12 kilometer untuk melakukan kegiatan rukun haji dan kegiatan diluar rukun haji. Ibadah haji memerlukan kapasitas fungsional dan keseimbangan yang baik sebagai syarat istitaah kesehatan untuk mencegah terjadinya kelelahan. Tujuan dari penelitian ini untuk menilai efek latihan berjalan terhadap kapasitas fungsional dan fungsi keseimbangan pada calon jemaah haji usia dewasa sehat.

Metode. Sebanyak 38 calon jemaah haji dewasa sehat dilakukan uji jalan 6 menit menggunakan rumus Nury prediksi VO2 maks dan uji timed up and go (TUG). Dilakukan randomisasi dan dibagi menjadi kelompok intervensi dan kontrol. Kelompok intervensi diberikan latihan berjalan minimal 6000 langkah per hari selama 30 menit dengan intensitas sedang sebanyak 3-5 kali seminggu dalam 8 minggu. Kelompok kontrol hanya diminta mencatat jumlah langkah per hari tanpa peresepan latihan. Pada akhir penelitian dilakukan kembali uji jalan 6 menit rumus Nury dan uji TUG, serta dilakukan analisis data.

Hasil. Kedua kelompok mengalami peningkatan prediksi VO2 maks namun tidak mengalami peningkatan nilai TUG pada akhir penelitian. Peningkatan prediksi VO2 maks pada kelompok perlakuan lebih tinggi dibandingkan dengan kelompok kontrol (p=0,007).

Kesimpulan. Latihan berjalan dapat meningkatkan kapasitas fungsional pada calon jemaah haji usia dewasa sehat, namun tidak memberikan efek peningkatan fungsi keseimbangan.

Kata kunci. Fungsi keseimbangan, jemaah haji, kapasitas fungsional.

---

ABSTRACTBackground. Hajj pilgrim is physical worship performed by pilgrims consist of walking at least 12 kilometer to complete the hajj principle and related activity. Hajj pilgrim needs good functional capacity and balance as a prerequisite of health to prevent fatigue. The aim of this study is to evaluate the effectivity of walking exercise on functional capacity and balance function for healthy adult pilgrim candidates.

Method. 6 minutes walk test (6MWT) and Timed Up and Go (TUG) test was done on 38 healthy adult hajj pilgrim candidate. VO2max was predicted using Nury Formula. The candidate was randomized into intervention and control group. Intervention group was given walking exercise, minimum of 6000 steps each day for 30 minutes, moderate intensity, 3-5 times a week for 8 weeks. The control group was not prescribed exercise, only asked to record the amount of steps taken each day. At the end of the study, 6MWT and TUG was reevaluated.  

Results. At the end of the study, both groups show improvement  on predicted VO2max but no improvement  on TUG time. Predicted VO2max improvement are higher on intervention group compared to control (p=0.007).

Conclusion. Walking exercise might increase functional capacity on healthy adult hajj pilgrim candidate, but has no effect on balance.

Keywords. Balance function, functional capacity, hajj pilgrim candidates.

"

"Latar Belakang : Penelitian perbandingan kesintasan pasien karsinoma paru bukan sel kecil usia lanjut stadium IIIB/IV yang menjalani kemoterapi dan non-kemoterapi sudah pernah diteliti di negara lain sebelumnya, namun penelitian tersebut di Indonesia belum pernah dilakukan. Penelitian-penelitian terdahulu belum banyak yang memperhitungkan faktor perancu seperti komorbiditas, jenis histopatologi, indeks massa tubuh, stadium, usia dan status fungsional dalam meneliti pengaruh kemoterapi terhadap kesintasan karsinoma paru bukan sel kecil usia lanjut.Tujuan : Mengetahui adakah perbedaan kesintasan satu tahun antara pasien kanker paru karsinoma bukan sel kecil usia lanjut stadium IIIB/IV yang menjalani kemoterapi dan non-kemoterapi.Metode : Kohort retrospektif dengan analisis kesintasan terhadap 232 pasien kanker paru karsinoma bukan sel kecil stadium IIIB/IV dan status fungsional ECOG 0-2 yang berobat jalan maupun rawat inap di RS Cipto Mangunkusumo dan RS Kanker Dharmais Januari 2007-April 2013, terbagi menjadi dua kelompok yaitu yang menjalani kemoterapi dan non-kemoterapi. Kurva Kaplan-Meier digunakan untuk mengetahui kesintasan satu tahun masing-masing kelompok. Analisis bivariat menggunakan uji log-rank, analisis multivariat menggunakan cox proportional hazard regression. Besarnya hubungan variabel kemoterapi dengan kesintasan dinyatakan dengan crude HR dan IK 95% serta adjusted HR dan IK 95% setelah dimasukkan variabel perancu.Hasil : Terdapat 232 pasien kanker paru karsinoma bukan sel kecil yang dibagi menjadi dua kelompok yaitu kemoterapi (118 subyek) dan non-kemoterapi (114 subyek). Persentase mortalitas satu tahun adalah 93,9% pada kelompok non-kemoterapi dan 57,6% pada kelompok kemoterapi. Median kesintasan kelompok non-kemoterapi adalah 2 bulan, sedangkan kelompok kemoterapi 9,73 bulan, p<0,001, HR 3,447(IK 95% 2,522-4,711). Analisis bivariat menunjukkan hubungan bermakna antara kemoterapi dengan kesintasan satu tahun. Analisis multivariat menunjukkan stadium adalah perancu kemoterapi terhadap kesintasan.Simpulan : Kesintasan satu tahun pasien kanker paru bukan sel kecil usia lanjut stadium IIIB/IV yang menjalani kemoterapi lebih baik dibandingkan dengan non-kemoterapi.

---

Background : The effects of chemotherapy on survival in elderly with advanced non-small cell lung cancer has been studied in other country before, but in Indonesia this topic hasn?t been studied. The influence of confounding factors such as comorbidity, histopathology, body mass index, functional status, age and stage of cancer were seldom considered in the earlier studies.Objective : To determine whether there?s a difference in one year survival between elderly with advanced non-small cell lung cancer who received chemotherapy and those who received non-chemoterapeutic approaches.Methods : Retrospective cohort design and survival analysis were used to 232 elderly with advanced non-small cell lung cancer (IIIB/IV) and performance status of ECOG 0-2 who visited Cipto Mangunkusumo Hospital and Dharmais Cancer Hospital between January 2007 and April 2013 that divided into 2 groups according to therapy that they received (chemotherapy and non-chemotherapy). Kaplan-Meier curve was used to evaluate the one year survival of each group. Bivariate analysis was conducted using log-rank test, multivariate analysis was conducted using Cox proportional hazard regression. The extend of relation between advancing age and survival was expressed with crude HR with 95% CI and adjusted HR with 95%CI after adjusting for confounders.Results : There were 232 elderly advanced non-small cell lung cancer that divided into two groups ; chemotherapy (118 subjects) and non-chemotherapy (114 subjects). One year mortality percentage were 93,9% and 57,6% to non-chemotherapy and chemotherapy group. The survival median were 2 months in non-chemotherapy group and 9,73 months in chemotherapy group, with p< 0,001 and HR 3,447 (95% CI : 2,522-4,711). Bivariate analysis showed statistically significant relation between chemotherapy and one year survival. Multivariate analysis showed that stage of cancer was a confounder to chemotherapy relation to survival.Conclusion : One year survival in elderly with advanced non-small cell lung cancer who received chemotherapy were better compared to those who received non-chemotherapeutic approaches."

"Latar Belakang: Studi epidemiologi menunjukkan bahwa DM merupakan salah satu faktor dalam proses terjadinya aterosklerosis dan mempengaruhi secara nyata kesaldtan dan kematian akibat PIK. Dibandingkan dengan penderita bukan DM, penderita DM 2-4 kali lebih banyak menderita P3K dan 2-4 kali lebih banyak mengalami kematian jangka pendek setelah menderita serangan infark miokard akut Dewabrata mendapati 23,2% penderita infark miokard akut yang di rawat di RSCM selama periode 1994-1999. Data di Indonesia tersebut belum banyak menggambarkan bagaimana karakteristik penderita DM tersebut saat terbukti menderita infark miokard akut. Dengan demildan, gambaran penderita DM yang mengalami sindrom koroner akut merupakan ha! yang renting untuk diketahui, baik karakteristik klinis maupun komplikasi yang muncul akibat S1CA tersebut.Tujuan. Penelitian ini ingin mengetahui prevalensi SKA pada penderita DM tipe-2. Penelitian ini juga ingin mengetahui karakteristik klinis dan komplikasi SKA pada penderita DM tipe-2 serta perbandingannya dengan penderita bukan DM. Metodologi. Studi potong lintang retrospektif untuk mengetahui prevalensi dan karakteristik klinis serta studi kohort retrospektif untuk mengetahui perbandingan komplikasi SKA pads penderita DM tipe-2 dan penderita bukan DM, terhadap penderita yang dirawat di ICCU RSCM periode 1 Januari 2001 s.d. 31 Desember 2005.Hasil. Didapatkan data: Prevalensi SKA penderita DM tipe-2: 34,2%. Awitan nyeri penderita DM lebih lama, 70,7% vs 53,4%, p=0,001; 1K 95%; DR=2,259 (1,372-3,719). Nyeri dada tidak khas, didapati penderita DM lebih banyak, 17,3% vs 9,8% p~ 0,041; 1K 95%; OR=1,713 (1,019-2,881)_ Komplikasi: Gagal jantung: penderita DM tipe-2 Iebih banyak: 39,35% vs 16,8%, p=0,001; 11(95%; RR-3,213 (1,992-5,182). Untuk komplikasi syok kardiogenik, didapati penderita DM tipe-2 Iebih banyak, 16,2% vs 8,9%, p= 0,031; IK 95%; RR==1,983 (1,057-3,721). Sedangkan komplikasi kematian didapati penderita DM tipe-2 lebih banyak, 17,3% vs 6,3%, dengan p= 0,001; 1K 95%; RR= 3,116 (1,556-6,239).Simpulan. Didapatkan perbedaan karakteristik klinis SKA antara penderita DM tipe-2 dengan penderita SKA bukan DM. Awitan nyeri lebih lama dan keluhan nyeri dada yang tidak khan, Iebih banyak didapati Dada penderita DM tipe-2. Didapatkan juga perbedaan dalam hat komplikasi SKA. Kejadian gagal jantung, syok kardiogenik dan kematian didapatkan lebih tinggi pada penderita DM tipe-2.

---

Background. Epidemiologic studies revealed diabetes mellitus (DM) as one of the factors involved in atherosclerosis process. DM also influence morbidity and mortality-related to coronary artery disease (CAD). Compared to non diabetic patients, type -2 DM patients suffer CAD 2-4 times more often and had increased short term mortality rate due to acute myocardial infarction 2-4 times more likely. During 1994-1999, Dewabrata found 23.2% of all acute myocardial infarction patients was diabetic patients treated in ICCU Cipto Mangunkusumo hospital. Unfortunately these data did not describe the clinical characteristic and complication ACS in type -2 DM patients. Therefore it is important to know the clinical characteristics and ACS related complications in type-2 DM patients.

Objectives. To know the prevalence of type-2 DM among ACS patients, to learn clinical characteristics and ACS related complications in type-2 DM compared to non diabetic patients.

Methods. A cross sectional retrospective study was performed to know the prevalence of ACS in type -2 DM patients and their clinical characteristics_ A retrospective cohort study was performed to compare the differences in ACS related complications in type -2 DM and non diabetic patients who were hospitalized in ICCU Cipto Mangunkusumo hospital during 5 years period (January 1st, 200I December 31st, 2005).

Results. Prevalence of Type-2 DM among ACS patients : 34.2%. The onset of chest pain in type-2 DM patients was longer, 70.7% vs 53.4%, p=0.40l; CI 95%; OR=2.259 (1.372-3.719). Aypical chest pain were often in type-2 DM patients, 17.3% vs 9.8%; p= 0.041; CI 95%; OR 1.713 (L019 2.881). Heart failure as complications were more often found in type-2 DM patients, 39.35% vs 16.8%, p=0.001; CI 95%; RR=3.213 (1.992-5.182), cardiogenic shock were more often found in type-2 DM patients, 16.2% vs 8.9%, p= 0.031; CI 95%; RR 1.983 (1.057-3.721), and death were more often found in type-2 DM patients, 17.3% vs 6.3%, p= 0.001; CI 95%; RR= 3.116 (L556-6.239).

Conclusions. There are differences in clinical characteristics of ACS between type-2 DM patients and non diabetic patients; which are longer onset of chestpain and atypical chestpain more often in type-2 DM patients. There are also differences in complications related ACS between Type-2 DM patients and non diabetic patients; heart failure, cardiogenic shock, and death more often in Type-2 DM patients."

"ABSTRAK Latar belakang : Pasien HIV berisiko 20-37 kali lipat terinfeksi TB, dan TBmerupakan penyebab kematian tertinggi pada HIV. Resistensi OAT menjadimasalah utama dalam pengobatan TB terutama pada pasien HIV, hal ini berujungpada peningkatan mortalitas dan biaya. Rifampisin merupakan OAT utama,dibuktikan dengan kesembuhan yang rendah pada regimen tanpa rifampisin,sehingga perlu diketahui prevalensi resistensi rifampisin dan faktor-faktor yangmempengaruhi pada pasien TB-HIV. Tujuan : Mengetahui prevalensi resistensi rifampisin pada pasien TB-HIV danfaktor-faktor yang mempengaruhi. Metode : Studi potong lintang terhadap 196 pasien TB-HIV yang menjalanipemeriksaan Xpert MTB-RIF di poli pelayanan terpadu HIV RSUPN CiptoMangunkusumo selama tahun 2012-2015. Analisa bivariat untuk mengetahuihubungan faktor-faktor dengan kejadian resistensi rifampisin. Analisa multivariatmenggunakan uji regresi logistik. Hasil dan Pembahasan : Pada 196 pasien yang menjadi subjek penelitian,didapatkan prevalensi resistensi rifampisin sebesar 13,8%. Usia, jenis kelamin,riwayat penggunaan ARV, dan TB ekstra paru tidak berhubungan dengankejadian resistensi rifampisin pada TB-HIV. CD4 < 100 mempengaruhi kejadianresistensi rifampisin (OR 2,57; 95% IK 0,99-6,69), Riwayat pengobatan TBmempengaruhi kejadian resistensi rifampisn (OR 3,98; 95% IK 1,68-9,44). Kesimpulan : Prevalensi resistensi rifampisin TB-HIV di RSUPN CiptoMangunkusumo sebesar 13,8%. Riwayat TB mempengaruhi kejadian resistensi rifampisin pada pasien TB-HIV. ABSTRACT Background: HIV patients have 20-37 fold risk of getting TB infection and TB isthe leading cause of death among them. Anti tuberculosis drug resistance is amajor problem in the treatment of tuberculosis with rifampicin as one of the maindrug. We need more information about prevalence of rifampicin resistance and itscontributing factors in TB-HIV patients. Aim: To determine the prevalence of rifampicin resistance in TB-HIV patientsand its contributing factors. Method : A cross sectional study of 196 TB-HIV patients who underwent XpertMTB/RIF examination at Cipto Mangunkusumo Hospital during the year 20122105.Correlationbetweenprevalenceofrifampicinresistanceanditscontributingfactorswas done using bivariate analysis. Multivariate analysis was done usinglogistic regression test. Result and Discussion : From 196 patients, we found prevalence of 13,8%rifampicin resistance. CD4 < 100 affects the incidence of rifampicin resistance(OR2.5;95% CI 0.99-6.69). Hiistory of TB treatment affects the incidence ofrifampicin resistance (OR3.98;95%CI 1.68-9.44). Conclusion : Prevalence of rifampicin resistance in TB-HIV patients in CiptoMangunkusumo Hospital is 13.8%. History of TB treatment affects the incidenceof rifampicin resistance in TB-HIV patients. ;Background: HIV patients have 20-37 fold risk of getting TB infection and TB isthe leading cause of death among them. Anti tuberculosis drug resistance is amajor problem in the treatment of tuberculosis with rifampicin as one of the maindrug. We need more information about prevalence of rifampicin resistance and itscontributing factors in TB-HIV patients. Aim: To determine the prevalence of rifampicin resistance in TB-HIV patientsand its contributing factors. Method : A cross sectional study of 196 TB-HIV patients who underwent XpertMTB/RIF examination at Cipto Mangunkusumo Hospital during the year 20122105.Correlationbetweenprevalenceofrifampicinresistanceanditscontributingfactorswas done using bivariate analysis. Multivariate analysis was done usinglogistic regression test. Result and Discussion : From 196 patients, we found prevalence of 13,8%rifampicin resistance. CD4 < 100 affects the incidence of rifampicin resistance(OR2.5;95% CI 0.99-6.69). Hiistory of TB treatment affects the incidence ofrifampicin resistance (OR3.98;95%CI 1.68-9.44). Conclusion : Prevalence of rifampicin resistance in TB-HIV patients in CiptoMangunkusumo Hospital is 13.8%. History of TB treatment affects the incidenceof rifampicin resistance in TB-HIV patients. ;Background: HIV patients have 20-37 fold risk of getting TB infection and TB isthe leading cause of death among them. Anti tuberculosis drug resistance is amajor problem in the treatment of tuberculosis with rifampicin as one of the maindrug. We need more information about prevalence of rifampicin resistance and itscontributing factors in TB-HIV patients. Aim: To determine the prevalence of rifampicin resistance in TB-HIV patientsand its contributing factors. Method : A cross sectional study of 196 TB-HIV patients who underwent XpertMTB/RIF examination at Cipto Mangunkusumo Hospital during the year 20122105.Correlationbetweenprevalenceofrifampicinresistanceanditscontributingfactorswas done using bivariate analysis. Multivariate analysis was done usinglogistic regression test. Result and Discussion : From 196 patients, we found prevalence of 13,8%rifampicin resistance. CD4 < 100 affects the incidence of rifampicin resistance(OR2.5;95% CI 0.99-6.69). Hiistory of TB treatment affects the incidence ofrifampicin resistance (OR3.98;95%CI 1.68-9.44). Conclusion : Prevalence of rifampicin resistance in TB-HIV patients in CiptoMangunkusumo Hospital is 13.8%. History of TB treatment affects the incidenceof rifampicin resistance in TB-HIV patients. "

"Latar Belakang. Sindrom pulih imun (SPI) TB adalah fenomena yang sudah dikenal luas yang dapat menyulitkan terapi antiretroviral. Saat ini belum ada penelitian mengenai insidens dan faktor prediktor terhadap terjadinya SPI TB di Indonesia. Dengan mengetahui insidens dan faktor prediktor yang berperan diharapkan dapat membantu klinisi mengidentifikasi terjadinya SPI TB dan merencanakan tindakan pencegahan dan penatalaksanaan.Tujuan. Mengetahui insidens, kesintasan, dan faktor-faktor prediktor terjadinya SPI TB pada pasien HIV dewasa yang dalam terapi ARV lini pertama.Metode. Penelitian kohort retrospektif terhadap 1344 pasien yang mendapat terapi antiretroviral untuk pertama kali di RSCM pada kurun waktu Januari 2007 - Desember 2011. Faktor prediktor yang diteliti adalah indeks massa tubuh (IMT) saat memulai ARV, jumlah CD4+ baseline, perubahan jumlah CD4+ setelah ARV (pada kedua jenis SPI), interval pemberian OAT dan ARV dan terdapatnya TB ekstraparu atau diseminata (pada yang paradoksikal). Analisis Cox Proportional Hazard Model dilakukan untuk mendapatkan adjusted Hazard Ratio (HR) prediktor yang diteliti.Hasil. Insidens kumulatif SPI TB paradoksikal adalah 11,73 % dengan incidence density 0,59 per 100 pasien-minggu, kesintasan kumulatif 87,1 % (SE 1,8 %), serta rerata kesintasan 22,14 minggu (interval kepercayaan [IK] 95% 21,56-22,70). Insidens kumulatif SPI TB unmasking adalah 3,05 % dengan incidence density 0,29 per 100 pasien-minggu, kesintasan kumulatif 96,6 % (SE 0,6 %), serta rerata kesintasan 11,82 minggu (interval kepercayaan [IK] 95% 11,74-11,90). IMT (adjusted HR 4,141; IK 95% 2,318 – 7,397) dan TB ekstra paru (adjusted HR 4,659; IK 95% 2,556 – 8,489) adalah faktor prediktor yang bermakna terhadap terjadinya SPI TB paradoksikal, sedangkan IMT (adjusted HR 2,755; IK 95% 1,214 – 6,254) menjadi satu-satunya faktor prediktor yang bermakna pada SPI TB unmasking.Kesimpulan : Insidens kumulatif SPI TB paradoksikal adalah 11,73 %, sedangkan insidens kumulatif SPI TB unmasking adalah 3,05 %. IMT dan TB ekstra paru adalah faktor prediktor yang bermakna terhadap terjadinya SPI TB paradoksikal, sedangkan IMT menjadi satu-satunya faktor prediktor yang bermakna pada SPI TB unmasking.

---

Background. Immune Reconstitution Inflammatory Syndrome (IRIS) TB is a widely-known phenomenon complicating antiretroviral therapy. There have been no research about incidence of IRIS TB in Indonesia and about predictors of IRIS TB. Determination of incidence and predictors of IRIS TB is expected to help clinicians to identify IRIS TB event earlier in order to manage the patient better and to prevent the event.

Objective. The objective of this research was to determine the incidence, survival, and predictors of IRIS TB event in adult HIV patient on first line antiretroviral therapy.

Method. Retrospective cohort was performed to 1344 patients (392 patients have been diagnosed with TB and 952 patients have not) who received antiretroviral therapy for the first time in RSCM Hospital between January 2007 – December 2011.

The predictors analyzed in this research were body mass index (BMI), baseline CD4+, changes of CD4+ after ARV therapy (in both type of IRIS TB), time interval between anti tuberculosis and antiretroviral therapy initiation, and the presence of extrapulmonary or disseminated TB (in paradoxical IRIS TB). Cox Proportional Hazard Model analysis was performed to get adjusted Hazard ratio (HR) of the observed predictors.

Result. Cumulative incidence of paradoxical IRIS TB was 11,73 % with incidence density 0,59 per 100 patient-week, cumulative survival 87,1 % (SE 1,8 %), and mean survival 22,14 weeks (CI 95% 21,56-22,70). Meanwhile, cumulative incidence of unmasking IRIS TB was 3,05 % with incidence density 0,29 per 100 patient-week, cumulative survival 96,6 % (SE 0,6 %), and mean survival 11,82 weeks (CI 95% 11,74-11,90).

BMI (adjusted HR 4,141; CI 95% 2,318 – 7,397) and extrapulmonary TB (adjusted HR 4,659; CI 95% 2,556 – 8,489) were predictors for paradoxical IRIS TB, while BMI (adjusted HR 2,755; CI 95% 1,214 – 6,254) was the only predictor for unmasking IRIS TB.

Conclusion: Cumulative incidence of paradoxical IRIS TB was 11,73 % with cumulative survival 87,1 % and mean survival 22,14 weeks. Meanwhile, Cumulative incidence of unmasking IRIS TB was 3,05 % with cumulative survival 96,6 % and mean survival 11,82 weeks. BMI and extrapulmonary TB were predictors for paradoxical IRIS TB, while BMI was the only predictor for unmasking IRIS TB."

"Latar Belakang: Peraturan Kementerian Kesehatan No.15 Tahun 2016 tentang Istithaah Kesehatan Jamaah haji menempatkan pasien dengan infeksi tuberkulosis dapat masuk dalam kategori tidak memenuhi syarat Isthitaah pada Tuberkulosis Totally drug Resistance (TDR) atau tidak memenuhi syarat Istithaah sementara pada Tuberkulosis sputum BTA Positif, Tuberkulosis Multi Drug Resistance, sehingga jamaah haji dengan TB berpotensi tidak dapat melaksanakan rukun islam kelima tersebut. Selain itu tingkat kebugaran dengan kategori cukup disyaratkan untuk memenuhi Istithaah kesehatan sesuai pasal 10. Saat ini belum ada laporan mengenai karakteristik dan faktor-faktor yang mempengaruhi Istithaah kesehatan pada jemaah haji dengan infeksi tuberkulosis Tujuan: Mengetahui karakteristik jamaah haji DKI Jakarta dengan infeksi tuberkulosis, mengetahui proporsi dan faktor-faktor terkait Istithaah kesehatan pada Jamaah haji dengan infeksi tuberkulosis. Metode: Studi potong lintang terhadap 31 jemaah haji DKI Jakarta yang sedang mendapatkan pengobatan tuberkulosis pada saat pelaksanaan ibadah haji tahun 2018. Kuesioner juga dilakukan terhadap Tim Kesehatan Haji Indonesia yang mendampingi subyek sebagai data tambahan. Analisa bivariat terhadap variabel kategorik-kategorik dilakukan menggunakan uji Chi Square atau bila persyaratannya tidak terpenuhi, maka dilakukan uji Fisher. Selanjutnya analisa multivariat menggunakan uji regresi logistik. Hasil: Pada studi ini didapatkan 31 subyek jemaah haji dengan Infeksi tuberkulosis dan menjalani pengobatan pada penyelenggaraan haji 2018. Dari data tersebut diketahui Sebagian besar subyek dalam penelitian ini berjenis kelamin laki-laki: 19/31(61,3 %) dan hampir seluruhnya berusia antara 40 hingga 60 tahun keatas: 30/31(96.8%). Sebagian besar subyek memiliki IMT yang normal atau lebih: 28/31 (90.3 %). Penegakan diagnosis TB pada jamaah haji lebih banyak melalui konfirmasi klinis: 17/31 (54.8%) dengan 93% subyek tidak bergejala. Seluruh subyek sudah menyelesaikan fase intensif dan memiliki BTA negatif yang dinyatakan layak terbang. Pada penelitian ini, mengacu kepada Peraturan Kementerian Kesehatan No.15 Tahun 2016, seluruh subyek memenuhi syarat Istithaah kesehatan haji dalam kriteria Memenuhi Syarat Istithaah Kesehatan Haji dengan Pendampingan, yaitu subyek menderita TB dengan sputum BTA negatif pada pemeriksaan akhir kelayakan terbang: 29/31 (94%) atau TB MDR yang sudah dinyatakan layak pergi haji oleh Tim Ahli Klinis TB MDR: 2/31 ( 0.6 %). Subyek jemaah haji dengan Infeksi tuberkulosis memiliki tingkat kebugaran cukup 12/31 (38.7%), kurang 13/31 (41.9%) dan sangat kurang 6/31 (19.30%), sesuai dengan kriteria kebugaran yang ditetapkan dalam penelitian ini. Hasil Kuesioner kepada Tim Kesehatan Haji Indonesia diketahui bahwa semua jamaah mampu melakukan Thawaf, Sai, dan wukuf di Padang Arafah sebagai rukun haji. Kesimpulan: Subyek yang sudah menyelesaikan fase intensif dengan sputum BTA yang negatif atau TB MDR yang dinyatakan layak berangkat haji oleh TIM Ahli Klinis TB MDR dinyatakan layak terbang pada pemeriksaaan kesehatan tahap ketiga dengan Memenuhi Syarat Istithaah dengan Pendampingan. Sebanyak 19/31 subyek jamaah haji dengan tuberkulosis memiliki tingkat kebugaran dibawah nilai cukup. Meskipun demikian jamaah haji dengan infeksi tuberkulosis masih mampu menjalankan rukun haji di tanah suci. Pada penelitian ini, komorbid, lama pengobatan dan kadar Hb tidak signifikan secara statistik mempengaruhi Istithaah kesehatan dengan infeksi tuberkulosis.

---

Background: Indonesian Ministry of Health Regulation No. 15 of 2016 on health policy for Hajj pilgrims puts patients with tuberculosis (TB) infection in the category of not fulfilling Isthahah (conditions Totally Drug Resistance TB) or does not meet temporary Istithaah ( Smear positif TB, Multi Drug Resistance (MDR) TB), so that pilgrims with TB potentially unable for hajj. In addition, the level of fitness with sufficient category is required according to chapter 10. At present, there is no reports on the health Istithaah of pilgrims with tuberculosis infection. Objective: To determine the characteristics of DKI Jakarta pilgrims with tuberculosis infection, to find out the proportion of low fitness levels for pilgrims with tuberculosis infection and to find out the factors related to Istithaah. Methods: A cross-sectional study of 31 Special Capitol Region of Jakarta pilgrims who were receiving tuberculosis treatment during the Hajj pilgrimage in 2018 was conducted; in addition, the Indonesian Hajj Health Team who accompanied the subjects was also included as additional data. Bivariate analysis of categoric-categoric variables are done using Chi Square method or as alternative, the Fisher method is used if the Chi Square test requirements are not fufille. Significant variables will be further analyzed with multivariate analysis using the logistic regression test Results: A total of 31 subjects of the Hajj were found with tuberculosis infection and underwent treatment. The majority were male: 19/31 and aged above 40 years old : 30/31, BMI normal or more: 28/31, diagnosis through clinical confirmation: 17/31 with 29/31 of subjects asymptomatic. All subjects have completed the intensive phase of TB treatment. Subjects with negative sputum smear at the final inspection of flightworthiness: 29/31 or MDR TB that has been declared eligible for Hajj by the MDR TB Clinical Expert Team: 2/31 .Subjects of pilgrims with tuberculosis infection have a sufficient fitness level of 12/31, less :13/31 and very less :6/31 , according to the fitness criteria established in this study. The results of the questionnaire to the Indonesian Hajj Health Team revealed that all pilgrims were able to do Thawaf, Sai, and stay in Padang Arafah. Conclusion: Subjects who have completed the intensive phase with negative sputum smear or MDR TB who were declared eligible by the MDR TB Clinical Expert Team were declared eligible to hajj with Istithaah Requirements with Assistance. As many as 19/31 of Hajj pilgrims with tuberculosis had a level of fitness below sufficient value. Nevertheless, subjects are still able to run the pillars of the Hajj. Nevertheless, subjects are still able to run the pillars of the Hajj. In this study, comorbidities, duration of treatment and HB level were not statistically significant affecting health status with tuberculosis infection."

"Pendahuluan. Penglepasan interferon-gamma oleh limfosit T yang antigenspecific akan meningkat setelah sel tersebut dipaparkan kembali dengan antigen tuberkulosis (TB) secara in vitro, khususnya apabila sel tersebut berasal dari lokasi infeksi TB aktif. Penelitian ini merupakan uji diagnostik pemeriksaan interferon-gamma release assay (IGRA) metode enzyme-linked immunospot (ELISPOT), yaitu T-SPOT.TB®, untuk deteksi TB pleura menggunakan spesimen sel mononuklear (MN) cairan pleura. Metode. Sebanyak 48 pasien efusi pleura terduga TB dengan karakteristik cairan pleura eksudatif berdasarkan kriteria Light dan dominasi sel MN lebih dari 50% dilakukan pemeriksaan T-SPOT.TB, biakan TB media cair Mycobacterial Growth Indicator Tube (MGIT), dan aktivitas adenosine deaminase (ADA) cairan pleura. Hasil. Dengan baku emas biakan TB MGIT didapatkan nilai sensitivitas 100%, spesifisitas 20%, nilai prediksi positif (NPP) 20%, dan nilai prediksi negatif (NPN) 100%. Dengan baku emas kombinasi biakan TB MGIT dan aktivitas ADA didapatkan nilai sensitivitas 100%, spesifisitas 88,89%, NPP 97,5%, dan NPN 100%. Kesimpulan. IGRA metode ELISPOT menggunakan spesimen cairan pleura merupakan pemeriksaan yang cepat dan bermanfaat sehingga dapat dipertimbangkan sebagai pemeriksaan tambahan pada pasien efusi pleura terduga TB.

---

Introduction. The release of interferon-gamma by antigen-specific T lymphocytes increases after rechallenge with tuberculosis (TB) antigen in vitro, especially at a localized site of TB infection. This study aimed to evaluate the diagnostic value of a commercial enzyme-linked immunospot (ELISPOT) assay for interferon-gamma, T-SPOT.TB®, in the diagnosis of TB pleurisy using pleural fluid mononuclear cells.

Methods. 48 subjects, presumed to have pleural TB with exudative pleural effusion by Light's criteria, dominated by mononuclear cells, had their pleural fluid specimen tested with T-SPOT.TB, TB Mycobacterial Growth Indicator Tube (MGIT) culture, and pleural fluid adenosine deaminase (ADA) activity.

Results. The sensitivity, specificity, positive and negative predictive values of the assay were 100%, 20%, 20%, 100%, respectively, if TB MGIT culture was used as the gold standard, and 100%, 88,89%, 97,5%, 100%, respectively, if TB MGIT culture and ADA activity of pleural fluid were used as the gold standard.

Conclusion. The ELISPOT assay for interferon-gamma is useful and rapid so it can be considered as a supplementary test to explore TB pleurisy."

"Pendahuluan: Tuberkulosis pleura merupakan bentuk TB ekstra paru paling umum kedua setelah TB kelenjar dan merupakan penyebab utama efusi pleura di daerah endemik TB. Diagnosis dan pengobatan cepat dan tepat sangat penting dalam pengelolaan TB pleura karena dapat menjadi progresif dan mengenai organ lain. Sampai saat ini, penegakkan diagnosis TB pleura masih menjadi tantangan. Tujuan: Mendapatkan model prediksi diagnosis TB pleura berdasarkan klinis, radiologi thoraks, analisa cairan pleura, ADA dan BTA metode sitosentrifugasi dan melakukan uji diagnostik pemeriksaan analisa cairan pleura, ADA dan BTA metode sitosentrifugasi pada pasien terduga TB pleura dengan biakan TB MGIT sebagai baku emas. Metode: Desain penelitian potong lintang. Subjek penelitian terdiri dari 50 pasien efusi pleura terduga TB. Dilakukan pemeriksaan analisa cairan pleura, ADA dan BTA metode sitosentrifugasi. Klinis pasien dan radiologi thoraks diperoleh dari rekam medik pasien. Analisis data dilakukan untuk uji diagnosis, analisis bivariat, multivariat, dan Receiving Characteristics Operator (ROC), dan analisis bootstrapping pada Kalibrasi Hosmer-Lemeshow. Hasil: Uji diagnosis analisa cairan pleura yaitu eksudat dengan MN>50% yaitu sensitivitas 83,3%, spesifisitas 38,6%, NPP 15,6%, NPN 94,4%. Pemeriksaan ADA yaitu sensitivitas 66,7%, spesifisitas 95,5%, NPP 66,7%, NPN 95,5%. Pemeriksaan BTA metode sitosentrifugasi yaitu sensitivitas 50%, spesifisitas 97,7%, NPP 75%, NPN 93,5%. Model prediksi diagnosis TB pleura adalah Logit (y) = -4,872+(2,025xEksudat dengan MN>50% +3,308xADA +2,438xBTA). Kesimpulan: Determinan diagnosis dan komponen sistem skor TB pleura adalah eksudat dengan MN>50%, ADA dan BTA metode sitosentrifugasi. Sistem skor diharapkan menjadi alat bantu diagnosis TB pleura. Berdasarkan uji diagnosis, pemeriksaan analisa cairan pleura yaitu eksudat dengan MN >50% baik untuk penapisan, sedangkan pemeriksaan ADA dan BTA metode sitosentrifugasi baik untuk menegakkan diagnosis.

---

Introduction: Pleural tuberculosis is the second commonest form of extrapulmonary TB after Lymph node and the main cause of pleural effusion in TB endemic areas. Early diagnosis and treatment is important because of its progressivity and spread to other organs. Until now, diagnosis of pleural TB remains a challenge.

Objective: This study aims to obtain prediction model based on clinical data, chest x-ray, pleural fluid analysis, ADA, and cytocentrifuged AFB, and perform diagnostic study on pleural fluid analysis, ADA, and cytocentrifuged AFB in suspected TB patients with TB MGIT culture as the gold standard.

Methods: This is a cross-sectional study on 50 pleural effusion patients suspected with TB. Pleural fluid analysis, ADA, and cytocentrifuged AFB tests were performed. Clincal data and x-rays were obtained from patient records. Statistical analysis include bivariate and multivariate analysis, ROC analysis, and bootstrapping in Hosmer-Lemeshow calibration test.

Results: The result of exudate and MN > 50% in pleural fluid analysis yielded 83.3% sensitivity, 38.6% specificity, 15.6% PPV, and 94.4% NPV. The result of > 40 U/L in ADA test showed 66.7% sensitivity, 95.5% specificity, 66.7% PPV, and 95.5% NPV. Cytocentrifuged AFB test yielded 50% sensitivity, 97.7% specificity, 75% PPV, and 93.5% NPV. Pleural TB prediction model was Logit (y) = -4,87 2+ 2,025 x exudate with MN > 50% + 3,308 x ADA + 2,438 x cytocentrifuged AFB.

Conclusion: Diagnostic determinants and pleural TB score components are exudate with MN > 50%, ADA, and cytocentrifuged AFB. Scoring system is expected to aid pleural TB diagnosis. Based on ROC analysis, exudate with MN > 50% in pleural fluid analysis is good for screening, while ADA and cytocentrifuged AFB tests are good for diagnosis."